CATHY BALZANO: Open Payments
NPI 1962905612 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,004 in 86 payments from 20 companies in 2025. Trend: 2023 $1,691 · 2024 $1,866 · 2025 $2,004
Food & beverage: $2,004
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $341 |
| AstraZeneca Pharmaceuticals LP | 5 | $298 |
| Novo Nordisk Inc | 14 | $284 |
| ABBVIE INC. | 10 | $167 |
| GlaxoSmithKline, LLC. | 10 | $157 |
| Corcept Therapeutics | 5 | $126 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Astellas Pharma US Inc | 3 | $94 |
| PFIZER INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
Products named: AIRSUPRA, Ozempic, TRELEGY ELLIPTA, KISUNLA, Korlym, GIMOTI, MOUNJARO, UBRELVY.
Industry payments across AZ — which companies pay providers there.
